Feb 24 • 11:19 UTC 🇫🇷 France Le Figaro

"A false accusation": Achraf Hakimi, the Moroccan player of PSG, sent to trial for rape

Achraf Hakimi, the Moroccan defender for Paris SG, is being sent to trial for rape following accusations made against him in February 2023, which he staunchly denies.

Achraf Hakimi, the 27-year-old Moroccan international and defender for Paris Saint-Germain (PSG), is facing a trial for rape after an accusation was made by a young woman in February 2023. The case has reignited public interest as it emerged that the player, who previously celebrated winning the UEFA Champions League with PSG in May, firmly maintains that the allegations are baseless. In a recent statement on social media platform X (formerly Twitter), Hakimi emphasized his belief that accusations alone can lead to a trial, regardless of their veracity, expressing concern for both innocent individuals and genuine victims of assault.

The ongoing legal situation presents significant implications for Hakimi's career and reputation, as athletes in the public eye often face heightened scrutiny when entangled in legal issues. The timing of the trial will be watched closely, as it coincides with a crucial period in the football season. Hakimi's performance on the field could be overshadowed by the attention this case draws, and there may be potential ramifications from his club, PSG, depending on the court's findings. The club has not yet publicly commented on the matter.

As this legal battle progresses, it raises important discussions about the intersection of sports, public perception, and the justice system. The case could influence how accusations of this severity are addressed within the world of sports and may set a precedent regarding the legal and social outcomes for high-profile athletes in similar situations. As both sides prepare for the trial, the discourse surrounding the case is likely to evolve, reflecting broader societal attitudes towards accusations of sexual violence and the complexities surrounding them.

📡 Similar Coverage